{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:34:01Z","timestamp":1774647241256,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s10067-015-2981-3","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T13:15:34Z","timestamp":1432818934000},"page":"1921-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand"],"prefix":"10.1007","volume":"34","author":[{"given":"Winston S. J.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Schollum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas H. N.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal K.","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"issue":"2","key":"2981_CR1","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"2","key":"2981_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"6","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Denton CP (2010) Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol 6(2):112\u2013116","journal-title":"Nat Rev Rheumatol"},{"key":"2981_CR3","doi-asserted-by":"crossref","unstructured":"Ho KT, Reveille J (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Research and Therapy 5(2):80\u201393","DOI":"10.1186\/ar628"},{"issue":"10","key":"2981_CR4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","volume":"30","author":"ME Krzyszczak","year":"2011","unstructured":"Krzyszczak ME et al (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30(10):1333\u20131339","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2981_CR5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2981_CR6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","volume":"30","author":"JD Reveille","year":"2001","unstructured":"Reveille JD et al (2001) Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 30(5):332\u2013346","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"2981_CR7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FM Meier","year":"2012","unstructured":"Meier FM et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 71(8):1355\u20131360","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2981_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","volume":"12","author":"S Mehra","year":"2013","unstructured":"Mehra S et al (2013) Autoantibodies in systemic sclerosis. Autoimmun Rev 12(3):340\u2013354","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2981_CR9","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","volume":"14","author":"M Hudson","year":"2012","unstructured":"Hudson M et al (2012) Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis. Arthritis Res Ther 14(2):R50","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2981_CR10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119(10):1005\u20131013","journal-title":"Ann Intern Med"},{"issue":"12","key":"2981_CR11","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.1780331210","volume":"33","author":"Y Okano","year":"1990","unstructured":"Okano Y, Medsger TA Jr (1990) Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum 33(12):1822\u20131828","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2981_CR12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","volume":"35","author":"CV Oddis","year":"1992","unstructured":"Oddis CV et al (1992) Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 35(10):1211\u20131217","journal-title":"Arthritis Rheum"},{"issue":"21\u201322","key":"2981_CR13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.cca.2011.06.041","volume":"412","author":"M Mahler","year":"2011","unstructured":"Mahler M et al (2011) Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta 412(21\u201322):1937\u20131943","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2981_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2249.1999.00964.x","volume":"117","author":"GR Harvey","year":"1999","unstructured":"Harvey GR et al (1999) Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clin Exp Immunol 117(2):395\u2013402","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2981_CR15","first-page":"104","volume":"34","author":"OC Meyer","year":"2007","unstructured":"Meyer OC et al (2007) Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 34(1):104\u2013109","journal-title":"J Rheumatol"},{"issue":"7","key":"2981_CR16","first-page":"537","volume":"32","author":"Y Shoenfeld","year":"1996","unstructured":"Shoenfeld Y et al (1996) Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma). Isr J Med Sci 32(7):537\u2013542","journal-title":"Isr J Med Sci"},{"issue":"1","key":"2981_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35\u201342","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2981_CR18","first-page":"301","volume":"21","author":"A Bardoni","year":"2003","unstructured":"Bardoni A et al (2003) Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 21(3):301\u2013306","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2981_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.090677","volume":"37","author":"O Meyer","year":"2010","unstructured":"Meyer O et al (2010) Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J Rheumatol 37(1):125\u2013130","journal-title":"J Rheumatol"},{"issue":"4","key":"2981_CR20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","volume":"42","author":"R Hesselstrand","year":"2003","unstructured":"Hesselstrand R et al (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42(4):534\u2013540","journal-title":"Rheumatology (Oxford)"},{"key":"2981_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-6-2","volume":"6","author":"JC Parker","year":"2009","unstructured":"Parker JC, Burlingame RW, Bunn CC (2009) Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis. J Autoimmune Dis 6:2","journal-title":"J Autoimmune Dis"},{"issue":"2","key":"2981_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.61.2.121","volume":"61","author":"T Dick","year":"2002","unstructured":"Dick T et al (2002) Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 61(2):121\u2013127","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2981_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s100670070001","volume":"19","author":"M Kikuchi","year":"2000","unstructured":"Kikuchi M, Inagaki T (2000) Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies. Clin Rheumatol 19(6):435\u2013441","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2981_CR24","first-page":"381","volume":"39","author":"S Jablonska","year":"1991","unstructured":"Jablonska S et al (1991) Immunological markers of the subsets of systemic scleroderma and its overlap. Arch Immunol Ther Exp 39(4):381\u2013390","journal-title":"Arch Immunol Ther Exp"},{"issue":"2","key":"2981_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2133.1990.tb08266.x","volume":"122","author":"M Jarzabek-Chorzelska","year":"1990","unstructured":"Jarzabek-Chorzelska M et al (1990) Are ACA and Scl 70 antibodies mutually exclusive? Br J Dermatol 122(2):201\u2013208","journal-title":"Br J Dermatol"},{"issue":"2","key":"2981_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2249.1999.00990.x","volume":"117","author":"CC Bunn","year":"1999","unstructured":"Bunn CC, Black CM (1999) Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol 117(2):207\u2013208","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"2981_CR27","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48(7):1956\u20131963","journal-title":"Arthritis Rheum"},{"key":"2981_CR28","doi-asserted-by":"crossref","unstructured":"Pauling JD, McHugh N (2012) The clinical aspects of autoantibodies. In: Varga J, et al. (ed) Scleroderma: from pathogenesis to comprehensive management. Springer Science+ Business Media. p. 209\u2013225","DOI":"10.1007\/978-1-4419-5774-0_18"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2981-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2981-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2981-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:42Z","timestamp":1559120262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2981-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2981-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}